Clinical Trials Directory

Trials / Completed

CompletedNCT01691001

Effect of Dexmedetomidine on Sevoflurane Requirements and Emergence Agitation in Children Undergoing Ambulatory Surgery

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Yonsei University · Academic / Other
Sex
Male
Age
1 Year – 5 Years
Healthy volunteers
Not accepted

Summary

Although the aetiology of emergence agitation (EA) derives from multiple factors, it is a frequent side effect of sevoflurane anaesthesia in children. Dexmedetomidine, a potent selective α2-adrenergic agonist, can reduce the doses of hypnotics, opioids, analgesics, and anaesthetics that must be concomitantly administered. This study was conducted to assess the effect of dexmedetomidine infusion on sevoflurane requirements and recovery profiles with EA in children undergoing ambulatory surgery.

Conditions

Interventions

TypeNameDescription
DRUGDexmedetomidinedexmedetomidine(vs saline) 1 mcg/kg iv bolus during 10minutes, and then, 0.1 mcg/kg/h dexmedetomidine(vs saline) was infused.
DRUGnormal saline

Timeline

Start date
2011-08-01
Primary completion
2012-03-01
Completion
2012-03-01
First posted
2012-09-24
Last updated
2012-09-24

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01691001. Inclusion in this directory is not an endorsement.